FDA Inspection 1309664 — Kurakula Srinivas, M.B.B.S.
The FDA completed an inspection of Kurakula Srinivas, M.B.B.S. on Feb 6, 2026 in Gajuwaka. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gajuwaka (India)
Additional details
Clinical BA/BE